DB Ashbourne

United Kingdom Founded: 2010 • Age: 16 yrs Acquired By Ethypharm
Procurement platform for generic medicines is provided by DB Ashbourne.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 3 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About DB Ashbourne

DB Ashbourne is a company based in United Kingdom founded in 2010 was acquired by Ethypharm in October 2015. The company has 3 employees as of December 31, 2021. DB Ashbourne operates in a competitive market with competitors including API Holdings, Medikabazaar, Remedial Health, giftHEALTH and Pharmacist Bang, among others.

  • Headquarter United Kingdom
  • Employees 3 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Orphea Limited
  • Date of Incorporation 08 Apr, 2016
  • Jurisdiction ROMFORD, ESSEX
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    3

    as on Dec 31, 2021

  • Acquired by
    Ethypharm

    (Oct 01, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of DB Ashbourne

Premium access

Detailed funding history for DB Ashbourne

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in DB Ashbourne

DB Ashbourne has secured backing from 1 investor. Prominent investors backing the company include Ethypharm.

All
Investor Description Founded Year Domain Location
Therapies for pain and addiction treatment are developed.
Locked Locked Locked
Premium access

Investor details for DB Ashbourne

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DB Ashbourne

Investments
Premium access

Investment portfolio details for DB Ashbourne

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - DB Ashbourne

Premium access

Detailed financials for DB Ashbourne

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Db Ashbourne Comparisons

DB Ashbourne Primary company
Description
Procurement platform for generic medicines is provided by DB...
Location
United Kingdom
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
3
As of 2021
Premium access

Peer comparison for DB Ashbourne

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of DB Ashbourne

DB Ashbourne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as API Holdings, Medikabazaar, Remedial Health, giftHEALTH and Pharmacist Bang, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Digital healthcare tools are offered for pharmacies and clinics management.
Locked Locked Locked
Online marketplace for medical supplies, equipment, and devices catering to healthcare providers
Locked Locked Locked
Supply chain management software is provided for pharmacies and insurers.
Locked Locked Locked
Provider of supply chain management platform
Locked Locked Locked
A mobile marketplace is provided for pharmacists and pharmaceutical companies.
Locked Locked Locked
Digital procurement platform is utilized by healthcare professionals and buyers.
Premium access

Detailed competitors of DB Ashbourne

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Db Ashbourne

Premium access

Complete news archive for DB Ashbourne

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DB Ashbourne

DB Ashbourne was founded in 2010.

DB Ashbourne is headquartered in United Kingdom.

Bertrand Deluard is the current CEO of DB Ashbourne.

As of Dec 31, 2021, the latest employee count at DB Ashbourne is 3.

DB Ashbourne, established in 2010 and currently in Acqui-Hired stage, focuses on healthtech, healthcare it, provider, administrative solutions, materials management, procurement, and generic. Provider of procurement platform of generic medicines. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

DB Ashbourne's top competitors include API Holdings, Medikabazaar and giftHEALTH.

DB Ashbourne has 1 investor. Key investors include Ethypharm.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available